Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine Administration Timings in Elderly TKA Patients
NCT07271849Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of nalbuphine in postoperative pain, sponsored by Shandong Provincial Qianfoshan Hospital. Started Oct 2025; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07271849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07271849.